ProSci

HEPACAM2 Antibody

Product Code:
 
PSI-7111
Product Group:
 
Primary Antibodies
Supplier:
 
ProSci
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blot (WB)
1 / 1
Western blot analysis of HEPACAM2 in mouse brain tissue lysate with HEPACAM2 antibody at (A) 0.5 μg/mL and (B) 1 μg/mL.

Western blot analysis of HEPACAM2 in mouse brain tissue lysate with HEPACAM2 antibody at (A) 0.5 μg/mL and (B) 1 μg/mL.

No additional charges, what you see is what you pay! *

CodeSizePrice
PSI-7111-0.02mg0.02mg£150.00
Quantity:
PSI-7111-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Additional Names:
HEPACAM2 Antibody: MIKI, MIKI, UNQ305/PRO346, HEPACAM family member 2, Mitotic kinetics regulator
Application Note:
HEPACAM2 antibody can be used for detection of HEPACAM2 by Western blot at 0.5 - 1 μg/mL.

Antibody validated: Western Blot in mouse samples. All other applications and species not yet tested.
Background:
HEPACAM2 Antibody: HEPACAM2 (Hepatocyte cell adhesion molecule 2), a type I N-linked transmembrane glycoprotein, belongs to the immunoglobulin superfamily. The exact function of HEPACAM2 is currently unknown, but the related protein HEPACAM forms cishomodimers on the cell surface to regulate the cell adhesion and may inhibit cell growth through suppression of cell proliferation. HEPACAM and HEPACAM2 mRNA are differentially regulated in canine tumors, with HEPACAM2 mRNA showing increased levels in adenomas, but decreased levels in metastatic carcinomas compared to normal tissues, while HEPACAM protein levels decreased in adenomas. It is therefore likely that HEPACAM2 plays a different role than HEPACAM in the development and progression to tumors.
Background References:
  • Klopfleisch R, Klose P, da Costa A, et al. HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph nodes metastases. BMC Veterinary Res. 2010; 6:15.
  • Moh MC, Tian Q, Zhang T, et al. The immunoglobulin-like cell adhesion molecule HEPACAM modulate cell adhesion and motility through direct interaction with the actin cytoskeleton. J. Cell Physiol. 2009; 219:382-91.
  • Lee LH, Moh MC, Zhang T, et al. The immunoglobulin-like cell adhesion molecule HEPACAM induces differentiation of human glioblastoma U373-MG cells. J. Cell Biochem. 2009; 107:1129-38.
Buffer:
HEPACAM2 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted species reactivity based on immunogen sequence: Bovine: (95%)
Immunogen:
Rabbit polyclonal HEPACAM2 antibody was raised against a 19 amino acid peptide near the carboxy terminus of human HEPACAM2.

The immunogen is located within amino acids 370 - 420 of HEPACAM2.
NCBI Gene ID #:
253012
NCBI Official Name:
HEPACAM family member 2
NCBI Official Symbol:
HEPACAM2
NCBI Organism:
homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
51 kDa
Protein Accession #:
NP_001034461
Protein GI Number:
86439957
Purification:
HEPACAM2 Antibody is affinity chromatography purified via peptide column.
Research Area:
Cancer,Cell Cycle
SPECIFICITY:
HEPACAM2 antibody is human, mouse and rat reactive. At least two isoforms of HEPACAM2 are known to exist; this antibody will detect both isoforms. HEPACAM2 antibody is predicted to not cross-react with HEPACAM.
Swissprot #:
A8MVW5
User NOte:
Optimal dilutions for each application to be determined by the researcher.